Soligenix (SNGX) EBITDA Margin (2010 - 2026)
Soligenix's EBITDA Margin came in at -7902.83% for FY2024, down 6986.49 percentage points from -916.34% in FY2023.
Powered by 
Analysis
Soligenix (SNGX) EBITDA Margin (2010 - 2026) Analysis & Trends
Going back to FY2010, Soligenix's EBITDA Margin data covers 15 years.
- EBITDA Margin carries a five-year change of -7676.33 percentage points (FY2019 to FY2024).
- The FY2024 figure represents the lowest annual EBITDA Margin in data going back to FY2010.
- Per Business Quant, earlier years put EBITDA Margin at -916.34% in FY2023 (+581.62 pp), -1497.96% in FY2022 (+87.05 pp), -1585.02% in FY2021 (-799.91 pp) and -785.10% in FY2020 (-558.61 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 39.16% |
| 10 | Soligenix | 5.74 Mn | -28.56 Mn | - | -3,915.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,915.01% |
| Mar 31, 2026 | -4,697.49% |
| Dec 31, 2025 | -4,826.60% |
| Sep 30, 2025 | -4,927.46% |
| Jun 30, 2025 | -3,957.40% |
| Mar 31, 2025 | -3,979.98% |
| Jun 30, 2024 | -74,427.28% |
| Mar 31, 2024 | -1,807.67% |
| Dec 31, 2023 | -872.62% |
| Sep 30, 2023 | -1,362.67% |
| Jun 30, 2023 | -786.00% |
| Mar 31, 2023 | -831.59% |
| Dec 31, 2022 | -971.54% |
| Sep 30, 2022 | -1,845.42% |
| Jun 30, 2022 | -1,476.74% |
| Mar 31, 2022 | -2,219.42% |
| Dec 31, 2021 | -1,630.23% |
| Sep 30, 2021 | -1,796.78% |
| Jun 30, 2021 | -1,387.10% |
| Mar 31, 2021 | -1,507.33% |
API Access
Soligenix EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SNGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SNGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SNGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();